Ethyl 1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclopropanecarboxylate → HCID 66577848、化合物
反応式
Br[C:2]1[CH:7]=[CH:6][C:5]([C:8]2[O:12][N:11]=[C:10]([CH3:13])[C:9]=2[C:14]([N:16]2[CH2:21][CH2:20][N:19]([S:22]([C:25]3[CH:30]=[CH:29][C:28]([Cl:31])=[C:27]([Cl:32])[CH:26]=3)(=[O:24])=[O:23])[CH2:18][CH2:17]2)=[O:15])=[CH:4][CH:3]=1.[CH2:33]([O:35][C:36]([C:38]1([C:41]2[CH:46]=[CH:45][C:44](B3OC(C)(C)C(C)(C)O3)=[CH:43][CH:42]=2)[CH2:40][CH2:39]1)=[O:37])[CH3:34]>>[CH2:33]([O:35][C:36]([C:38]1([C:41]2[CH:46]=[CH:45][C:44]([C:2]3[CH:7]=[CH:6][C:5]([C:8]4[O:12][N:11]=[C:10]([CH3:13])[C:9]=4[C:14]([N:16]4[CH2:21][CH2:20][N:19]([S:22]([C:25]5[CH:30]=[CH:29][C:28]([Cl:31])=[C:27]([Cl:32])[CH:26]=5)(=[O:23])=[O:24])[CH2:18][CH2:17]4)=[O:15])=[CH:4][CH:3]=3)=[CH:43][CH:42]=2)[CH2:39][CH2:40]1)=[O:37])[CH3:34]参加物
3
実験手順
Prepared according to the procedure described in Example 2, Step 2, using [5-(4-bromo-phenyl)-3-methyl-isoxazol-4-yl]-[4-(3,4-dichloro-benzenesulfonyl)-piperazin-1-yl]-methanone and 1-[4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl]-cyclopropanecarboxylic acid ethyl ester.
後処理
- customPrepared
出典と根拠
- ORDレコード
- ord-b8d96777fbb942e9a0b6196f0a393415